The Chemist's Companion Guide to Patent Law (Miller/Chemical Patent Law) || Cases Cited

P1: OTA/XYZ P2: ABCcaselist JWBS025-Miller April 30, 2010 12:8 Printer Name: TBD

CASES CITED

Ex parte A, 17 USPQ2d 1716 (Bd. Pat. App. & Inter. 1990), 185

Abbott Laboratories v. Geneva Pharmaceuticals, Inc. 182 F.3d 1315 (CAFC 1999),98

In re Adamson, 275 F.2d 952 (CCPA 1960), 242

A.F. Stoddard & Co. v. Dann, 564 F. 2d 556 (D.C. Cir. 1977), 121

AK Steel Corp. v. Sollac, 344 F.3d 1234 (CAFC 2003), 146

In re Albrecht, 514 F.2d 1389 (CCPA 1975), 210

Allen Eng’g Corp. v. Bartell Industries, Inc., 299 F.3d 1336 (CAFC 2002), 97

In re Aller, 220 F.2d 454 (CCPA 1955), 266

Amgen Inc. v. Hoechst Marion Roussel, 314 F.3d 1313 (CAFC 2003), 170

In re Antonie, 559 F.2d 618 (CCPA 1977), 267

Ariad Pharmaceuticals v. Eli Lilly (CAFC 2009), 304

Atofina v. Great Lakes Chem. Corp., 441 F.3d 991 (CAFC 2006), 185

In re Baird, 16 F.3d 380 (CAFC 1994), 252

Bayer v. Housey, 340 F.3d 1367 (CAFC 2003), 12

Bayer Corp. v. Schein Pharm. Co. 301 F.3d 1306 (CAFC 2002), xiii, 315

In re Bergy, 596 F.2d 952 (CCPA 1979), 158

In re Blaisdell, 242 F.2d 779 (CCPA 1957), 97

Ex parte Bland, 3 USPQ2d 1103 (Bd. Pat. App. & Inter. 1986), 202

Ex parte Blattner, 2 USPQ2d 2047 (Bd. Pat. App. & Inter. 1987), 222

In re Brana, 51 F.3d (Fed. Cir. 1995), 107, 165

Brenner v. Manson, 383 US 519 (1966), 161

Bristol-Myers Squibb Company v. Rhone Poulenc Rorer, Inc. et al., 326 F.3d 1226(CAFC 2003), 66

In re Burckel 592 F.2d 1175 (CCPA 1979), 233

In re Burhans, 154 F.2d 690 (CCPA 1946), 269

Burlington Indus. v. Dayco Corp., 849 F.2d 1418, 1422 (CAFC 1988), 78

Burroughs Wellcome Co. v. Barr Labs, Inc., 40 F.3d 1223 (CAFC 1994), 127

The Chemist’s Companion Guide to Patent Law, by Chris P. Miller and Mark J. EvansCopyright C© 2010 John Wiley & Sons, Inc.

321


322 CASES CITED

Catalina Marketing Int’l. v. Coolsavings.com, Inc., 289 F.3d 801 (CAFC 2002), 138

Chemcast Corp. v. Arco Indus. Corp., 913 F.2d 923 (CAFC 1990), 314

In re Chupp, 816 F.2d 643 (CAFC 1987), 228

In re Cofer, 354 F.2d 664 (CCPA 1966), 279

Corning Glass Works v. Sumitomo Electric U.S.A., Inc., 868 F.2d 1251 (CAFC 1989),138

Correge v. Murphy, 705 F.2d 1326 (CAFC 1983), 95

In re Crockett, 279 F.2d 274 (CCPA 1960), 270

In re Cronyn, 890 F.2d 1158 (CAFC 1989), 85

Cross v. Izuka, 753 F.2d (Fed. Cir. 1985), 107, 165

Cuno Engineering Corp. v. Automatic Devices Corp., 314 U.S. 84 (1941), 203

In re Davies, 475 F.2d 667 (CCPA 1973), 227

Ex Parte Davis, 80 USPQ 448 (Board of Appeals, 1948), 142

In re Dillon, 919 F.2d 688 (CAFC 1990), 212

In re Dilnot, 319 F.2d 188 (CCPA 1963), 269

D.L. Auld Co. v. Chroma Graphics Corp., 714 F.22d 1144 (CAFC 1983), 97

In re Donohue, 766 F.2d 531 (CAFC 1985), 170, 194

Ecolochem, Inc. v. Southern California Edison Co., 227 F.3d 1361 (CAFC 2000),217

Emery v. Ronden, 188 USPQ 264 (Bd. Pat. Inter. 1974), 87

Environmental Designs, Ltd. v. Union Oil Co., 713 F.2d 693 (Fed. Cir. 1983), 201

Ferring v. Barr, 437 F.3d 1181 (CAFC 2006), 227

Fina Technology, Inc. v. Ewen, 265 F.3d 1325 (CAFC 2001), 118

Fonar Corp. v. General Elec. Co., 107 F.3d 1543 (CAFC 1997), 314

Frank’s Casing Crew & Rental Tools, Inc. et. al. v. PMR Technologies, et. al., 292F.3d 1363 (CAFC 2002), 123

Fromson v. Advance Offset Plate, Inc., 720 F.2d 1565, 1570 (CAFC 1983), 164

In re Gay, 309 F.2d 768 (CCPA 1962), 305

Glaxo v. Novopharm, 52 F.3d 1043 (CAFC 1995), 314

In re Gleave (CAFC 2009), 185

In re Gordon, 733 F.2d 900 (CAFC 1984), 221

In re GPAC, 57 F.3d 1573, 1580 (CAFC 1995), 250

Graham v. John Deere, 383 U.S. 1 (1966), 204

Gravers Tank and Manufacturing Co. v. Linde Air Products Co., 339 U.S. 605 (1950),9

In re Gray, 53 F.2d 520 (CCPA 1931), 142


CASES CITED 323

Griswold v. Connecticutt, 381 US 479 (1965), 59

Group One, Ltd. v. Hallmark Cards, Inc., 254 F.3d 1041 (CAFC 2001), 98

In re Hall, 781 F.2d 897 (CAFC 1986), 85

In re Hedges, 783 F.2d 1038 (CAFC 1986), 250

In re Herz, 537 F.2d 549 (CCPA 1976), 146

Hess v. Advanced Cardiovascular Sys., Inc., 106 F.3d 976 (CAFC 1997), 128

In re Hirao, 535 F.2d 67 (CCPA 1976), 200

Ex parte Hirschler, 110 USPQ 384 (Bd. App. 1952), 85

Hobbs v. United States, 451 F.2d 849 (5th Cir. 1971), 98

In re Hoeksema, 399 F.2d 269 (CCPA 1968), 242

Hofmann-LaRoche v. Promega Corp., 323 F.3d 1354 (CAFC 2003), 76, 307

Honeywell v. ITT Industrials et al., 452 F.3d 1312 (CAFC 2006), 154

Hotchkiss v. Greenwood, 51 U.S. 248 (1850), 199

Ex parte Humber, 217 USPQ 265 (Bd. App. 1961), 233

International Glass Co. v. United States, 408 F.2d 395 (Ct. Cl. 1968), 95

In Re John Dash and Patrick S. Keefe (CAFC 2004), 166

In re Joly, 376 F.2d 906 (CCPA 1967), 162

In re Kahn, 441 F.3d 977 (CAFC 2006), 208

In re Kathawala 9 F.3d 942 (CAFC 1993), 99

In re Katz, 687 F.2d 450 (CCPA 1982), 85

Kilbey v. Thiele, 199 USPQ 290 (Bd. Pat. Appeals and Interferences 1976), 90

Kingsdown Med. Consultants, Ltd. v. Hollister, Inc. 849 F.2d 1418 (CAFC 1988), 79

In re Klopfenstein, 380 F.3d 1345 (Fed. Cir. 2004), 85

In re Kirk, 376 F.2d 936 (CCPA 1967), 163

Knoll Pharmaceutical Co. v. Teva Pharmaceuticals USA, 367 F.3d 1381 (CAFC2004), 271

In re Kollar, 286 F.3d 1326 (CAFC 2002), 98

In re Kratz, 592 F.2d 1169 (CCPA 1979), 276

KSR v Teleflex 550 U.S. 398 (2007), 202, 209

Land v. Dreyer, 155 F.2d 383 (CCPA 1946), 127

In re Langer, 503 F.2d 1380 (CCPA 1974), 166

Mackay Radio & Telegraph Co. v. Radio Corp. of America, 306 U.S. 86 (1939), 159

Ex Parte Markush, 1925 C.D. 126 (Comm’r Pat. 1925), 146

Mars, Inc. v. H.J. Heinz Co., 377 F.3d 1369 (CAFC, 2004), 149


324 CASES CITED

In re Marzocchi, 439 F.2d 220, 223-224 (CCPA 1971), 306

Massachusetts Institute of Technology v. AB Fortia, 774 F.2d 1104 (CAFC 1985), 85

In re May, 574 F.2d 1082 (CCPA 1978), 240

Ex parte Mead Johnson & Co. 227 USPQ 78 (Bd. Pat. App. & Inter. 1985), 226

MedImmune, Inc. v. Genetech, Inc. 549 U.S. 118 (2007), 70, 119

In re Merck & Co., 800 F.2d 1091 (CAFC 1986), 231, 259

Merck & Co. Inc. v. Teva Pharmaceuticals USA, Inc. 395 F.3d 1364 (CAFC 2005),151

Merck KgaA v. Integra Life Sciences I, Ltd. 545 US 193 (2005), 13

Metabolite Labs., Inc. v. Lab Corp. of Am. Holdings, 370 F.3d 1354 (CAFC 2004),160

In re Mlot-Fijalkowski 676 F.2d 666 (CCPA 1982), 202

Moleculon Research Corp. v. CBS, Inc., 793 F.2d 1261 (CAFC 1986), 96

Molins PLC v. Textron, Inc., 48 F.3d 1172 (CAFC 1995), 74

Moore v. United States, 194 USPQ 423 (Ct. Cl. 1977), 99

Ex Parte Mowry 91 USPQ 219 (Bd. App. 1950), 235

Mueller Brass Co. v. Reading Industries, Inc., 352 F.Supp. 1357 (E.D.Pa. 1972), 126

Nartron Corp. v. Schukra U.S.A., Inc., 558 F.3d 1352 (CAFC 2009), 128

Nelson v. Bowler, 626 F.2d 853 (CCPA 1980), 165

Nilssen et al. v. Osram Sylvania, et al. 504 F.3d 1223 (CAFC 2007), 20

Norian Corp. v. Stryker Corp., 363 F.3d 1321 (CAFC 2004), 143

In re Ochiai, 71 F.3d 1565 (CAFC 1995), 128, 240

In re Oda, 443 F.2d 1200 (CCPA 1971), 290

Oka v. Youssefiyah, 849 F.2d 581 (CAFC 1988), 128

Ortho-McNeil Pharmaceuticals, Inc. v. Caraco Pharmaceutical Laboratories, Ltd.,476 F.3d 1321 (CAFC 2007), 153

Panduit Corp. v. Dennison Mfg. Co. 810 F.2d 1561 (CAFC 1987), 205

Pannu v. Iolab Corp., 155 F.3d 1344 (CAFC 1998), 121, 125

In re Papesch, 315 F.2d 381 (CCPA 1963), 226

In re Payne, 606 F.2d 303 (CCPA 1979), 226

Perricone v. Medicis Pharm. Corp., 432 F.3d 1368, 1376 (CAFC 2005), 185

In re Petering, 301 F.2d 676 (CCPA 1962), 189

Petersen v. Fee Int’l Ltd., 381 F. Supp 1071 (W.D. Okla. 1974), 99

In re Peterson, 315 F.3d 1325 (CAFC 2003), 263

Pfaff v. Wells Electronics, Inc., 525 US 55 (1998), 97

Pfizer, Inc. v. Ranbaxy Laboratories Ltd., F.3d 1284 (CAFC 2006), 52

Phillips v. AWH Corp., 415 F.3d 1303 (CAFC 2005), 149, 205


CASES CITED 325

Pitney Bowes, Inc. v. Hewlett-Packard Co., 182 F.3d 1298 (CAFC 1999), 139

In re Portola Packaging, 110 F.3d 786 (CAFC 1997), 56

Procter & Gamble (P&G) v. Teva Pharmaceuticals (CAFC 2009), 88

Purdue Pharma. v. Faulding Inc., 230 F.3d 1320 (CAFC 2000), 291

Rasmusson v. Smithkline Beecham Corp., 413 F.3d 1318 (CAFC 2005), 170

Regents of the University of California v. Howmedica Inc., 210 USPQ 727 (D. NJ1981), 86

Regents of the Univ. of Cal. v. Lilly, 119 F.3d 1559 (CAFC 1997), 302

Renishaw PLC v. Marposs Societa’ Per Azioni, 158 F.3d 1243 (CAFC 1988), 151

Ruiz v. A.B. Chance Co., 234 F.3d 654 (CAFC 2000), 250

In re Ruschig, 379 F.2d 990 (CCPA 1967), 293

SanDisk Corp. v. Memorex Products, Inc., 415 F.3d 1278 (CAFC 2005), 154

SanDisk Corp. v. STMicroelectronics, Inc. 480 F.3d 1372, (CAFC 2007), 70

Schering Corp. v. Geneva Pharmaceuticals et al., (CAFC 2003), 196

Scott v. Koyama, 281 F.3d 1243 (CAFC 2002), 87

In re Seagate Technology, LLC, 487 F.3d 1360 (CAFC 2007), 8

In re Slayter, 276 F.2d 408, 411, 125 USPQ 345 (CCPA 1960), 185

In re Smith, 714 F.2d 1127 (CAFC 1983), 96

Smith v. Hayashi, 209 USPQ 754 (Bd. Pat. App. & Inter. 1980), 273

In re Soni, 54 F.3d 746 (CAFC 1995), 230

In re Spada, 911 F.2d 705 (CAFC 1990), 194

SRI International, Inc. v. Internet Security Systems, Inc., 511 F.3d 1186 (CAFC 2007),86

Stark v. Advanced Magnetics, Inc., 119 F.3d 1551 (CAFC 1997), 122

In re Steminski, 444 F.2d 581 (CCPA 1971), 212, 253

In re Stephen W. Comiskey, (CAFC 2009), 160

Sterling Drug Inc. v. Watson, 135 F. Supp. 173 (D.D.C. 1955), 240

In re Swanson, (CAFC 2008), 58

Titanium Metals Corp. v. Banner, 778 F.2d 775 (CAFC 1985), 192, 260

Townsend v. Smith, 36 F.2d 292 (CCPA 1930), 95, 126

Trans-World Mfg. Corp. v. Al Nyman & Sons, Inc., 750 F.2d 1552 (CAFC 1994),121

Union Carbide Chems. & Plastics Tech. Corp. v. Shell Oil Co., 308 F.3d 1167 (CAFC2002), 151

United States Gypsum Co. v. National Gypsum Co., 74 F.3d 1209 (CAFC 1996), 314

Univ. of Rochester v. G.D. Searle & Co., 358 F.3d 916 (CAFC, 2004), 300


326 CASES CITED

Vulcan Eng’g Co. v. Fata Aluminum, Inc., 278 F.3d 1366, 1373 (CAFC 2002), 249

Waldemar Link Gmbh & Co. v. Osteonics Corp., 32 F.3d 556 (CAFC 1994), 292

In re Wands, 858 F.2d 731 (CAFC 1988), 304

Warner-Jenkinson Company, Inc. v. Hilton Davis Chemical Co., 520 U.S. 17 (1997),9

Wetmore v. Quick, 536 F.2d 937 (CCPA 1976), 127

In re Wilder, 563 F.2d 457 (CCPA 1977), 237

In re Woodruff , 919 F.2d 1575 (CAFC 1990), 261

In re Wyer, 655 F.2d 221 (CCPA 1981), 85

Yamanouchi Pharmaceutical Co., Ltd. v. Danbury Pharmacal, Inc., 231 F.3d 1339(CAFC 2000), 214

In re Ziegler, 992 F.2d 1197 (CAFC 1993), 161

Documents

The Chemist's Companion Guide to Patent Law (Miller/Chemical Patent Law) || Cases Cited